What is the EVERY?
Headquartered in San Francisco, The EVERY Company is a biotechnology innovator specializing in the development of proteins and functional ingredients traditionally sourced from animals. By utilizing advanced precision fermentation, the company creates high-quality, sustainable alternatives that cater to the evolving needs of the global food industry. Their market position is defined by a commitment to decoupling food production from animal agriculture, thereby addressing critical challenges in supply chain resilience and environmental sustainability.
The company's core technology platform enables the production of proteins that offer the same taste, texture, and functionality as their conventional counterparts. This technological edge has allowed The EVERY Company to forge strategic partnerships with major food manufacturers, positioning them at the forefront of the alternative protein revolution. Their business model focuses on B2B integration, providing food brands with the essential building blocks to create cleaner, more ethical consumer products.
How much funding has the EVERY raised?
the EVERY has raised a total of $315.1M across 8 funding rounds:
Angel/Seed
$1.7M
Angel/Seed
$20M
Debt
$350K
Multiple Rounds
$238M
Series D
$55M
Angel/Seed (2015): $1.7M, investors not publicly disclosed
Angel/Seed (2019): $20M, investors not publicly disclosed
Debt (2020): $350K supported by PPP
Debt (2021): $8M featuring Horizon Technology Finance Management LLC
Series A (2021): $15M, investors not publicly disclosed
Series B (2021): $40M, investors not publicly disclosed
Series C (2021): $175M led by Mcwin and RAGING CAPITAL MANAGEMENT
Series D (2025): $55M supported by Grosvenor, McWin Capital Partners, TO VC (to.vc, and Bloom8
Key Investors in the EVERY
Grosvenor
Founded in 1677, Grosvenor is a privately-owned international property company that offers residential, commercial, retail, office, hotels, and leisure properties.
McWin Capital Partners
McWin Capital Partners is a private investment firm that specializes in partnering with founders and CEOs to drive sustainable disruption in the food service and food technology sectors.
TO VC
TO VC is an early-stage venture capital fund that invests in innovative founders who are transforming energy production, food growth, infrastructure development, and climate change adaptation.
What's next for the EVERY?
With the successful closure of this latest financing, The EVERY Company is well-positioned to accelerate its commercial expansion and deepen its research and development capabilities. The strategic allocation of these funds will likely focus on scaling production capacity to meet industrial-level demand and expanding the company's portfolio of functional protein ingredients. As the firm moves into this next phase of growth, it is expected to prioritize market penetration in key international regions and further optimize its fermentation processes for cost-efficiency.
The ongoing support from high-profile investors signals strong confidence in the company's long-term vision to reshape the global food system. Future milestones will likely include the launch of new product lines and the strengthening of its intellectual property portfolio, ensuring that The EVERY Company remains a dominant force in the rapidly maturing food technology landscape.
